HOT-HMV and health economics: from research to reality

In this episode, the focus is on the relationship between clinical outcomes, financial costs and societal impact. Dr Patrick Murphy explains the importance of collecting robust health economic data, using the example of the HOT-HMV trial that explored home NIV for COPD. If you’re interested in health economics, value-based healthcare, clinical commissioning or simply appreciate clear and informed discussion of a critical aspect of modern clinical research, you’ll want to tune in. Guests: Dr Patrick Murphy - Lane Fox Respiratory Unit, Guy’s and St Thomas’ Hospital, London. Melike Deger-Wehr - Health Economics and Outcomes Research Director, ResMed. Host: Nina Wiklund is ResMed’s Global Medical Marketing Content Lead, and has a burning enthusiasm for clinical research. She is especially interested in the additional insights and possibilities real-world evidence can add to existing RCTs.  The podcast OnAir, with Clinical Respiratory News (CRN) is a medical education non-promotional for healthcare professionals organised by ResMed. Learn more at https://webinars.resmed.eu/podcasts-list/. This podcast is intended for healthcare professionals only. Disclaimer: This programme is non promotional and is sponsored by ResMed. The speakers are being compensated and/or receiving an honorarium from ResMed in connection with this programme. The content contained in this programme was jointly developed by the speakers and ResMed, and is not eligible for continuing medical education (CME) credits. Listen to OnAir with Clinical Respiratory News, the podcast that brings you fresh insights and thought-provoking discussions about hot topics in sleep and breathing health. © ResMed